Gene expression profiling and hierarchical clustering analysis

KK Kati Kämpjärvi
NM Netta Mäkinen
MM Miika Mehine
SV Salla Välipakka
OU Outi Uimari
EP Esa Pitkänen
HH Hanna-Riikka Heinonen
TH Tuomas Heikkinen
JT Jaana Tolvanen
AA Anne Ahtikoski
NF Norma Frizzell
NS Nanna Sarvilinna
JS Jari Sjöberg
RB Ralf Bützow
LA Lauri A Aaltonen
PV Pia Vahteristo
request Request a Protocol
ask Ask a question
Favorite

Gene expression profiles of 14 leiomyomas from four HLRCC patients and three FH-deficient sporadic tumours and their corresponding normal myometrial tissue samples were analysed together with 58 uterine leiomyomas and corresponding normal samples from which we had both expression and whole-genome sequencing data in-house (19 MED12 mutation-positive and 39 MED12 and FH wild-type tumours) (Mehine et al, 2013, 2016). Gene expression data was constructed using Affymetrix GeneChip Human Exon 1.0 ST Arrays (Affymetrix) at the Biomedicum Functional Genomics Unit, Helsinki, Finland. The expression data was analysed with Partek Genomic Suite v. 6.5 (Partek Incorporated, St Louis, MO, USA) using re-mapped Brainarray Custom CDF files (HuEx10stv2_Hs_ENSG, Version 16). All samples were quantile-normalised by the Robust Multichip Average method and adjusted for probe sequence and GC-content. Unsupervised hierarchical clustering analysis (Cosine dissimilarity) was performed with 1% most variable genes (n=372), defined by the coefficient of variation calculated across all tumour samples.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A